• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
DeviceCoreValve Evolut R System and CoreValve Evolut PRO System
Generic Nameaortic valve, prosthesis, percutaneously delivered
ApplicantMedtronic, Inc.
710 medtronic parkway
minneapolis,, MN 55432
PMA NumberP130021
Supplement NumberS051
Date Received06/29/2018
Decision Date08/24/2018
Product Code NPT 
Advisory Committee Cardiovascular
Supplement Typenormal 180 day track
Supplement Reason labeling change - indications/instructions/shelf life/tradename
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
Approval for modifying the labeling to remove the precaution regarding patients with a congenital bicuspid aortic valve.